The appellant, Brandon Mott, appealed a Consent and Capacity Board decision that found him incapable of consenting to anti-psychotic medication.
Mott, diagnosed with schizophrenia, denied his illness and argued the Board failed to consider reported side effects and the role of substance use in his mental health history.
The Board had concluded Mott was unable to appreciate the foreseeable consequences of declining treatment due to his inability to recognize the manifestations of his mental condition, a finding upheld by the court.
The appeal was dismissed, with the court finding no palpable and overriding error in the Board's decision.
